A Study in Healthy Men to Test How Itraconazole Influences the Amount of Zongertinib (BI 1810631) in the Blood
Clinical trial NCT05833139 · COMPLETED
Trial details
- NCT number
- NCT05833139
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-14
- Primary completion
- 2023-06-12
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.